Brainstorm Cell Therapeutics Inc. (BCLI)
收市後：
| 前收市價 | 0.3740 |
| 開市 | 0.3756 |
| 買盤 | 0.3655 x 100 |
| 賣出價 | 0.3764 x 100 |
| 今日波幅 | 0.3502 - 0.3763 |
| 52 週波幅 | 0.1300 - 3.3400 |
| 成交量 | |
| 平均成交量 | 1,001,806 |
| 市值 | 25.15M |
| Beta 值 (5 年，每月) | 0.29 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.4000 |
| 業績公佈日 | 2024年5月13日 - 2024年5月17日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 2.50 |
Insider MonkeyBrainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Greetings, and welcome to the BrainStorm Cell Therapeutics Third Quarter 2023 Earnings Call. At this time, participants are in a listen-only mode. As a reminder, this call is being recorded. And I would now like to introduce your host for today’s […]
- Insider Monkey
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q1 2023 Earnings Call Transcript
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q1 2023 Earnings Call Transcript May 15, 2023 Brainstorm Cell Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.15, expectations were $-0.16. Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics First Quarter 2023 Earnings Call. At this time, participants are in a listen-only mode. As a reminder this call […]
